Swan Winifred L 4
4 · NxStage Medical, Inc. · Filed Feb 22, 2018
Insider Transaction Report
Form 4
Swan Winifred L
SVP and General Counsel
Transactions
- Sale
Common Stock
2018-02-20$24.48/sh−3,500$85,680→ 9,770 total - Exercise/Conversion
Common Stock
2018-02-20$11.03/sh+3,000$33,090→ 13,270 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-02-20−3,000→ 11,542 totalExercise: $11.03From: 2013-04-04Exp: 2023-03-03→ Common Stock (3,000 underlying)
Footnotes (1)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2016.